Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aldo M Roccaro

Showing results (1-10 of 132) with videos related to

Pageof 14
Sort By:
Blood|June 8, 2023
Starving multiple myeloma cells via CDK7 inhibitionAntonio Sacco, Aldo M Roccaro
Blood|March 7, 2024
Waking up exhausted BCMA-specific T cells in myelomaAntonio Sacco, Aldo M Roccaro
Blood|September 11, 2025
ClpP: a new Achilles' heel in myelomaAntonio Sacco, Aldo M Roccaro
Microrna (Shariqah, United Arab Emirates)|July 30, 2014
microRNA aberrations and their role in supporting hematologic malignanciesAldo M Roccaro, Irene M Ghobrial
Recent Patents on Anti-Cancer Drug Discovery|January 29, 2008
Bortezomib in the treatment of cancerAldo M Roccaro, Angelo Vacca, Domenico Ribatti
Epigenomics|November 30, 2011
Epigenetics in Waldenström's macroglobulinemiaAntonio Sacco, Irene M Ghobrial, Aldo M Roccaro
Clinical Investigation|October 29, 2011
Novel agents in Waldenström macroglobulinemiaGhayas C Issa, Irene M Ghobrial, Aldo M Roccaro
Cancers|October 20, 2020
Epigenetic Aberrations in Multiple MyelomaCinzia Caprio, Antonio Sacco, Viviana Giustini, et al.
Frontiers in Cell and Developmental Biology|March 17, 2022
Editorial: The Bone Marrow Niche in Normal and Malignant HaematopoiesisMichela Colombo, Ruggiero Norfo, Giada Bianchi, et al.
Current Cancer Drug Targets|February 17, 2017
Multiple Myeloma and the Immune MicroenvironmentYawara Kawano, Aldo M Roccaro, Irene M Ghobrial, et al.
Pageof 14

Showing results (1-10 of 132) with videos related to

Sort By:
Pageof 14
Blood|June 8, 2023
Starving multiple myeloma cells via CDK7 inhibitionAntonio Sacco, Aldo M Roccaro
Blood|March 7, 2024
Waking up exhausted BCMA-specific T cells in myelomaAntonio Sacco, Aldo M Roccaro
Blood|September 11, 2025
ClpP: a new Achilles' heel in myelomaAntonio Sacco, Aldo M Roccaro
Microrna (Shariqah, United Arab Emirates)|July 30, 2014
microRNA aberrations and their role in supporting hematologic malignanciesAldo M Roccaro, Irene M Ghobrial
Recent Patents on Anti-Cancer Drug Discovery|January 29, 2008
Bortezomib in the treatment of cancerAldo M Roccaro, Angelo Vacca, Domenico Ribatti
Epigenomics|November 30, 2011
Epigenetics in Waldenström's macroglobulinemiaAntonio Sacco, Irene M Ghobrial, Aldo M Roccaro
Clinical Investigation|October 29, 2011
Novel agents in Waldenström macroglobulinemiaGhayas C Issa, Irene M Ghobrial, Aldo M Roccaro
Cancers|October 20, 2020
Epigenetic Aberrations in Multiple MyelomaCinzia Caprio, Antonio Sacco, Viviana Giustini, et al.
Frontiers in Cell and Developmental Biology|March 17, 2022
Editorial: The Bone Marrow Niche in Normal and Malignant HaematopoiesisMichela Colombo, Ruggiero Norfo, Giada Bianchi, et al.
Current Cancer Drug Targets|February 17, 2017
Multiple Myeloma and the Immune MicroenvironmentYawara Kawano, Aldo M Roccaro, Irene M Ghobrial, et al.
Pageof 14